This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Arconic (ARNC) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Arconic's (ARNC) cost reduction actions and sustained momentum in automotive should lend support to its earnings in the third quarter.
Will PPG Industries (PPG) Disappoint This Earnings Season?
by Zacks Equity Research
Adverse impacts of recent hurricanes and earthquakes along with currency headwinds are likely to impact PPG Industries' (PPG) Q3 results.
7 Reasons to Add Huntsman (HUN) Stock to Your Portfolio Now
by Zacks Equity Research
Based on its compelling prospects, we believe Huntsman (HUN) has plenty of upside potential.
Kronos Worldwide (KRO) Up 24% in 3 Months: What's Driving It?
by Zacks Equity Research
Strong Q2 results and upbeat outlook have contributed to the rally in Kronos Worldwide's (KRO) shares.
Innophos Holdings (IPHS) Stock Up 15% in 3 Months: Here's Why
by Zacks Equity Research
Strong Q2 results, healthy outlook and upbeat prospects stemming from Novel Ingredients buyout have provided a boost to Innophos' (IPHS) shares.
Kraton Corp (KRA) Up 18% in 3 Months: What's Driving It?
by Zacks Equity Research
Strong Q2 results and upbeat outlook have contributed to a rally in Kraton's (KRA) shares.
Here's Why Ingevity (NGVT) is a Solid Investment Choice Now
by Zacks Equity Research
Ingevity Corporation (NGVT) is poised to gain from end-market demand for its products. Also, building new plants and acquiring meaningful business will prove advantageous.
New Strong Buy Stocks for October 6th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
4 Basic Materials Stocks to Invest in Ahead of Q3 Earnings
by Zacks Equity Research
Basic Materials sector has outperformed the S&P 500 year to date. Four stocks hold strong potential for outperformance and are worth buying before the third-quarter earnings starts.
Ingevity Corporation (NGVT) in Focus: Stock Moves 6.4% Higher
by Zacks Equity Research
Ingevity Corporation (NGVT) was a big mover last session, as the company saw its shares rise over 6% on the day amid huge volumes.
Quaker Chemical's Growth Prospects Solid: Time to Buy?
by Zacks Equity Research
On Jul 4, Zacks Investment Research upgraded Quaker Chemical Corporation (KWR) to a Zacks Rank #1 (Strong Buy).
International Flavors (IFF) Beats Q4 Earnings & Revenues
by Zacks Equity Research
International Flavors & Fragrances Inc. (IFF) reported better-than-expected earnings for fourth-quarter 2016. Adjusted earnings came in at $1.22 per share, above the Zacks Consensus Estimate of $1.16.
The Zacks Analyst Blog Highlights: Kronos Worldwide, Ingevity, LyondellBasell Industries NV, Celanese Corporation and Albemarle
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Kronos Worldwide, Ingevity, LyondellBasell Industries NV, Celanese Corporation and Albemarle
American Vanguard Subsidiary Buys Fungicide Product Line
by Zacks Equity Research
A fully-owned subsidiary of American Vanguard Corporation (AVD), AMVAC Chemical Corporation has acquired the FFIII fungicide product line from the Plant Nutrient Group of The Andersons, Inc, (ANDE).